Designed to encourage interaction and collaboration, SCOPE X emphasizes detailed case studies, peer-driven discussions, and ...
Good day, everyone, and welcome to Pfizer Pflash, a spotlight on the PD-1 VEGF bispecific PF-4404 clinical development strategy. Today's call is being recorded. At this time, I would like to turn the ...
As clinical development grows increasingly complex, the industry has recognized the critical role of centralized processes and risk‑based monitoring in ensuring high‑quality, reliable data. Regulatory ...
Basket Trials Evaluating Tazemetostat Combinations for Multiple New Heme and Solid Tumor Cancers to be Initiated in Second Half 2021 “The recent accelerated approvals of TAZVERIK in Epithelioid ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today ...
Platform leverages muscle biology to de-risk development and identify new therapeutic targets ahead of clinical entry ...
Engagement will assess KALA’s clinical assets, development options, and AI-enabled analytical opportunities, including the ...
Orionis Biosciences, a privately held, clinical‑stage life sciences company focused on discovery, design and development of precision medicines for cancer and immune system-related disorders, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results